RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
EARLY RESULTS OF A PHASE II STUDY ADDING PERI-TRANSPLANT RITUXIMAB TO NONMYELOABLATIVE CONDITIONING AND ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) FOR PATIENTS (PTS) WITH HIGH-RISK FLUDARABINE-REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
2012-01-01 Sorror ML; Storer B; Sandmaier BM; Chauncey T; Bruno B; Andersen NNS; Hogan WJ; Storb R; Maloney D
Efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation at risk of hepatis B virus reactivation
2010-01-01 Giaccone L; Festuccia M; Marengo A; Resta I; Sorasio R; Pittaluga F; Fiore F; Boccadoro M; Rizzetto M; Marzano A; Bruno B
Evaluation of a panel of monoclonal antibodies (MAB) that recognize canine CD34.
1996-01-01 McSweeney PA; Rouleau KA; Nash RA; Bolles L; KrizanacBengez L; Andrews R; Woodger P; Bruno B; Wayner E; Storb R; Wallace PM
Ex vivo expanded, retrovirally transduced cytotoxin T-lymphocytes (CTL) enhance engraftment of DLA-haploidentical marrow.
1999-01-01 Georges GE; Storb R; Thompson JD; Taranova A; Bruno B; Sale G; Beauchamp M; Kiem HP; Lyons R; Nash RA
Ex vivo expansion of canine dendritic cells from CD34(+) bone marrow progenitor cells
1999-01-01 Hagglund HG; McSweeney PA; Mathioudakis G; Bruno B; Georges GE; Gass MJ; Moore P; Sale GE; Storb R; Nash RA
Exhaled Nitric Oxide (eNO) and Pulmonary Function after Total Body Irradiation (TBI) Based Non Myeloablative Conditioning Regimens and Allogeneic Hematopoietic Cell Transplant.
2005-01-01 Luisa Giaccone; Caterina B. Bucca; Roberto Sorasio; Marcello Rotta; Gabriele Aitoro; Erica Panaro; Luisa Brussino; Giovanni Rolla; Mario Boccadoro; and Benedetto Bruno
Exhaled nitric oxide (eNO) and pulmonary function after total body irradiation (TBI) based non myeloablative conditioning regimens and allogenic hematopoietic cell transplant
2005-01-01 Giaccone L; Bucca CB; Sorasio R; Rotta M; Aitoro G; Panaro e; Brussino L; Rolla G; Boccadoro M; Bruno B
Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation
2006-01-01 Baron F; Storb R; Storer BE; Maris MB; Niederwieser D; Shizuru JA; Chauncey TR; Bruno B; Forman SJ; McSweeney PA; Maziarz RT; Pulsipher MA; Agura ED; Wade J; Sorror M; Maloney DG; Sandmaier BM
Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia
2005-01-01 Sorror ML; Maris MB; Sandmaier BM; Storer BE; Stuart MJ; Hegenbart U; Agura E; Chauncey TR; Leis J; Pulsipher M; McSweeney P; Radich JP; Bredeson C; Bruno B; Langston A; Laken MR; Al-Ali H; Blume KG; Storb R; Maloney DG
Hematopoietic Cell Transplants (HCT) from HLA-Matched Related (MRD) and Unrelated (URD) Donors for Patients with Hematologic Malignancies Using Low-Dose TBI Conditioning.
2005-01-01 Brenda M. Sandmaier; M.B. Maris; D.G. Maloney; T.A. Gooley; J.A. Shizuru; D.W. Niederwieser; T.R. Chauncey; F. Sahebi; E. Agura; R.T. Maziarz; B.Bruno; M. Pulsipher; A.A. Langston; J. Wade; P.A. McSweeney; E. Epner; W. Bethge; S.J. Forman; K.G. Blume; and R. Storb
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| EARLY RESULTS OF A PHASE II STUDY ADDING PERI-TRANSPLANT RITUXIMAB TO NONMYELOABLATIVE CONDITIONING AND ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) FOR PATIENTS (PTS) WITH HIGH-RISK FLUDARABINE-REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) | 2012 | Sorror ML; Storer B; Sandmaier BM; Chauncey T; Bruno B; Andersen NNS; Hogan WJ; Storb R; Maloney D | |
| Efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation at risk of hepatis B virus reactivation | 2010 | Giaccone L; Festuccia M; Marengo A; Resta I; Sorasio R; Pittaluga F; Fiore F; Boccadoro M; Rizzetto M; Marzano A; Bruno B | |
| Evaluation of a panel of monoclonal antibodies (MAB) that recognize canine CD34. | 1996 | McSweeney PA; Rouleau KA; Nash RA; Bolles L; KrizanacBengez L; Andrews R; Woodger P; Bruno B; Wayner E; Storb R; Wallace PM | |
| Ex vivo expanded, retrovirally transduced cytotoxin T-lymphocytes (CTL) enhance engraftment of DLA-haploidentical marrow. | 1999 | Georges GE; Storb R; Thompson JD; Taranova A; Bruno B; Sale G; Beauchamp M; Kiem HP; Lyons R; Nash RA | |
| Ex vivo expansion of canine dendritic cells from CD34(+) bone marrow progenitor cells | 1999 | Hagglund HG; McSweeney PA; Mathioudakis G; Bruno B; Georges GE; Gass MJ; Moore P; Sale GE; Storb R; Nash RA | |
| Exhaled Nitric Oxide (eNO) and Pulmonary Function after Total Body Irradiation (TBI) Based Non Myeloablative Conditioning Regimens and Allogeneic Hematopoietic Cell Transplant. | 2005 | Luisa Giaccone; Caterina B. Bucca; Roberto Sorasio; Marcello Rotta; Gabriele Aitoro; Erica Panaro; Luisa Brussino; Giovanni Rolla; Mario Boccadoro; and Benedetto Bruno | |
| Exhaled nitric oxide (eNO) and pulmonary function after total body irradiation (TBI) based non myeloablative conditioning regimens and allogenic hematopoietic cell transplant | 2005 | Giaccone L; Bucca CB; Sorasio R; Rotta M; Aitoro G; Panaro e; Brussino L; Rolla G; Boccadoro M; Bruno B | |
| Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation | 2006 | Baron F; Storb R; Storer BE; Maris MB; Niederwieser D; Shizuru JA; Chauncey TR; Bruno B; Forman SJ; McSweeney PA; Maziarz RT; Pulsipher MA; Agura ED; Wade J; Sorror M; Maloney DG; Sandmaier BM | |
| Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia | 2005 | Sorror ML; Maris MB; Sandmaier BM; Storer BE; Stuart MJ; Hegenbart U; Agura E; Chauncey TR; Leis J; Pulsipher M; McSweeney P; Radich JP; Bredeson C; Bruno B; Langston A; Laken MR; Al-Ali H; Blume KG; Storb R; Maloney DG | |
| Hematopoietic Cell Transplants (HCT) from HLA-Matched Related (MRD) and Unrelated (URD) Donors for Patients with Hematologic Malignancies Using Low-Dose TBI Conditioning. | 2005 | Brenda M. Sandmaier; M.B. Maris; D.G. Maloney; T.A. Gooley; J.A. Shizuru; D.W. Niederwieser; T.R. Chauncey; F. Sahebi; E. Agura; R.T. Maziarz; B.Bruno; M. Pulsipher; A.A. Langston; J. Wade; P.A. McSweeney; E. Epner; W. Bethge; S.J. Forman; K.G. Blume; and R. Storb |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 04-CONTRIBUTO IN ATTI DI CONVEGNO 167
- 04-CONTRIBUTO IN ATTI DI CONVEGNO... 167
Data di pubblicazione
- 2010 - 2018 47
- 2000 - 2009 107
- 1994 - 1999 13
Rivista
- BLOOD 83
- HAEMATOLOGICA 35
- BONE MARROW TRANSPLANTATION 34
- BIOLOGY OF BLOOD AND MARROW TRANS... 8
- ANNALS OF ONCOLOGY 2
- JOURNAL OF CLINICAL ONCOLOGY 2
- CURRENT OPINION IN HEMATOLOGY 1
- HLA 1
- JOURNAL OF HEPATOLOGY 1
Lingua
- eng 166
- ita 1
Accesso al fulltext
- no fulltext 157
- open 10